Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsUTMD +0.41%73 EV-to-EBIT is 12.92 as of Aug. 27, 2026, which is 5% below its 10-year median of 13.57. GuruFocus rates UTMD with a GF Score™ of 73/100 and a GF Value™ of $57.89 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 481 Medical Devices & Instruments companies, Utah Medical Products ranks better than 66.74% on this metric.
Utah Medical Products (NAS:UTMD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Utah Medical Products's Enterprise Value for the quarter that ended in Jun. 2026 was $132.23 Mil.
Utah Medical Products's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Utah Medical Products's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's EV-to-EBIT falls into.
Utah Medical Products's current Enterprise Value is $138.37 Mil.
Utah Medical Products's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Utah Medical Products (UTMD) has a EV-to-EBIT of 12.92 as of Aug. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Utah Medical Products and its competitors. This is near median its historical median of 13.57. Over the past decade, Utah Medical Products' EV-to-EBIT has ranged from 6.83 to 21.44. According to the industry distribution chart, Utah Medical Products ranks #160 out of 481 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is Utah Medical Products' EV-to-EBIT too high?
Utah Medical Products' current EV-to-EBIT of 12.92 is near median its 10-year median of 13.57. Over the past 10 years, this metric has ranged from a low of 6.83 to a high of 21.44. The Medical Devices & Instruments industry median EV-to-EBIT is 18.93. Utah Medical Products' value of 12.92 is 31.7% below this industry median. Based on the distribution chart, Utah Medical Products ranks #160 out of 481 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Utah Medical Products has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' EV-to-EBIT compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #160 out of 481 companies for EV-to-EBIT. This puts Utah Medical Products in the upper half of its industry. The industry median EV-to-EBIT is 18.93. Utah Medical Products' value of 12.92 is 31.7% below this benchmark. Historically, Utah Medical Products' own EV-to-EBIT has ranged from 6.83 to 21.44 over the past decade. While the company's 10-year median is 13.57 vs. the industry median of 18.93, Utah Medical Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.93, based on 481 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current EV-to-EBIT of 12.92 is 31.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current EV-to-EBIT is 12.92, which is near median its own 10-year median of 13.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Based on GuruFocus' analysis, Utah Medical Products (UTMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $57.89, compared to a current price of $70.84 — trading 22.4% above its estimated fair value. The current EV-to-EBIT is 12.92, which is near median its 10-year median of 13.57 and 31.7% below the Medical Devices & Instruments industry median of 18.93. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Utah Medical Products (UTMD), the current EV-to-EBIT is 12.92 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (UTMD) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of $70.84 is trading 22.4% above its estimated GF Value™ of $57.89.
GuruFocus considers Utah Medical Products to be Modestly Overvalued.
Key valuation signals for UTMD:
EV-to-EBIT: 12.92 (near median its 10-year median of 13.57)
GF Value™: $57.89 vs. price of $70.84 (22.4% above fair value)
Industry Position: 31.7% below the Medical Devices & Instruments median (#160 of 481)
No single metric tells the full story. See the UTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for UTMD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UTMD has been successfully added to your 
